|
Symbol
|
CNMBKB | 1055BC | Z0AVGZ | RMALNV | RMAIAV | ACPCSQ | RMAZBV | ADSVTQ | RMA2MV | LDYILK | RMBOSV | RMBN0V | RSZRCH | RMBHMV | RMBN7V | RVZRCH | RVIRCH | RMAWKV | RMBIVV | RMAIFV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible with European Knock-In | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | LUKB Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti |
|
Underlying
|
Bachem Hldg. AG / Galenica AG / Novartis AG / Straumann Hldg. AG | Galenica AG / Nestlé S.A. / Partners Group Hldg. AG | Galenica AG / Novartis AG / Roche PS / Sonova Hldg. AG | Galderma Group AG / Galenica AG / Ypsomed Hldg. AG | Galderma Group AG / Galenica AG / Straumann Hldg. AG | Galenica AG / Sonova Hldg. AG / Straumann Hldg. AG | Galenica AG / Sandoz Group AG / Straumann Hldg. AG | ABB N / Galenica AG / Sika AG | Galenica AG / Siegfried Hldg. AG / Straumann Hldg. AG | Galenica AG / UBS Group AG / VAT Group | Galenica AG / Medacta Group / Sandoz Group AG / Ypsomed Hldg. AG | Dottikon ES Holding AG / Ems-Chemie Hldg. AG / Galenica AG | Galenica AG / Lonza Group N / Straumann Hldg. AG | Galderma Group AG / Galenica AG / Sandoz Group AG / Straumann Hldg. AG | Beiersdorf AG / Galenica AG / Nestlé S.A. / Unilever N.V. | Bachem Hldg. AG / Galenica AG / Siegfried Hldg. AG | Galderma Group AG / Galenica AG / Sandoz Group AG | Ems-Chemie Hldg. AG / Galderma Group AG / Galenica AG | Galenica AG / Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Galenica AG / Lonza Group N / Novartis AG / Sandoz Group AG |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
07.08.2026 | 13.08.2026 | 24.09.2026 | 07.12.2026 | 14.12.2026 | 16.12.2026 | 29.12.2026 | 05.02.2027 | 14.05.2027 | 22.12.2026 | 23.07.2027 | 07.02.2028 | 20.08.2027 | 03.09.2027 | 03.09.2027 | 20.09.2027 | 13.03.2028 | 04.10.2027 | 10.05.2027 | 29.11.2027 |
| Bid | 78.92 | 50.02 | - | 101.20 | 100.20 | 99.01 | 99.40 | 88.31 | 98.00 | - | 93.60 | 88.80 | 98.09 | 99.60 | 75.20 | 98.52 | 100.03 | 102.40 | 102.90 | 100.20 |
| Ask | - | 50.52 | - | 102.60 | 101.40 | 99.81 | 100.60 | - | 99.20 | - | 94.80 | 90.20 | 98.89 | 100.80 | - | 99.32 | 100.83 | 103.60 | 104.10 | 101.40 |